Background illustration for clinical trials search

Stem Cells Clinical Trials

Find clinical trials for stem cells. Search for stem cells clinical trials in different cities and states across the United States.

Filter

Umbilical Cord Blood for Stem Cell Transplantation in Treating Young Patients With Malignant or Nonmalignant Diseases

for
Childhood Langerhans Cell Histiocytosis, Fanconi Anemia,
Location: Hershey PA
Sponsor: Milton S. Hershey Medical Center

Sex: All

Age: 0 - 21

Code: NCT00084695

Phase 2, Recruiting

Tandem Peripheral Blood Stem Cell (PBSC) Rescue for High Risk Solid Tumors

for
Ewing's Sarcoma, Soft Tissue Sarcoma, Hepatoblastoma,
Location: Chicago IL
Sponsor: Ann & Robert H Lurie Children's Hospital of Chicago

Sex: All

Age: 0 - 21

Code: NCT00179816

Phase 1, Phase 2, Recruiting

Prehab Prior to Stem Cell Transplantation in Multiple Myeloma

for
Multiple Myeloma, Exercise, Prehabilitation
Location: Edmonton
Sponsor: University of Alberta

Sex: All

Age: 18+

Code: NCT06280924

Recruiting

Hematopoietic Stem Cell Dysfunction in the Elderly After Severe Injury

for
Trauma Injury
Location: Gainesville FL
Sponsor: University of Florida

Sex: All

Age: 18+

Code: NCT02577731

Recruiting

Improving Cognitive Function in Older Adults Undergoing Stem Cell Transplant

for
Leukemia, Lymphoma, Multiple Myeloma,
Location: Omaha NE
Sponsor: University of Nebraska

Sex: All

Age: 19+

Code: NCT04898790

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions

for
Autoimmune Diseases, Cardiovascular Disorders,
Location: Culver City CA
Sponsor: Thomas Advanced Medical LLC

Sex: All

Age: 18+

Code: NCT04684602

Phase 1, Phase 2, Recruiting

A Study of Tacrolimus/Methotrexate/Ruxolitinib Versus Post-Transplant Cyclophosphamide/Tacrolimus/Mycophenolate Mofetil in Non-Myeloablative/Reduced Intensity Conditioning Allogeneic Peripheral Blood Stem Cell Transplantation (BMT CTN 2203)

for
Graft-versus-host Disease (GVHD)
Location: Boston MA, New York NY, Philadelphia PA, Richmond VA,
Sponsor: Incyte Corporation

Sex: All

Age: 18+

Code: NCT06615050

Phase 3, Recruiting

Carfilzomib Based Chemotherapy Mobilization for Autologous Stem Cell Transplants in Multiple Myeloma

for
Multiple Myeloma
Location: Hackensack NJ
Sponsor: Hackensack Meridian Health

Sex: All

Age: 18+

Code: NCT03909412

Phase 1, Recruiting

Using Induced-Pluripotent Stem Cells to Model Cancer Therapy-Related Adverse Events

for
Hematopoietic and Lymphatic System Neoplasm,
Location: Jacksonville FL
Sponsor: Mayo Clinic

Sex: All

Age: 18+

Code: NCT06640010

Recruiting

Alpha/Beta T Cell and CD19+ B Cell Depletion in Allogeneic Stem Cell Transplantation in Patients With Malignant Diseases

for
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia,
Location: Gainesville FL
Sponsor: University of Florida

Sex: All

Age: 0 - 39

Code: NCT05800210

Phase 2, Recruiting

Pathogen Identification in Pediatric Hematopoietic Stem Cell Transplant Patients With Suspected Lower Respiratory Tract Infection

for
Lower Respiratory Tract Infections
Location: San Francisco CA
Sponsor: Pediatric Blood and Marrow Transplant Foundation, Inc.

Sex: All

Age: 0 - 21

Code: NCT02926612

Recruiting

A Reduced-Intensity Conditioning Regimen (Cyclophosphamide, Pentostatin, Anti-thymocyte Globulin) Followed by Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Patients With Refractory or Recurrent Severe Aplastic Anemia

for
Recurrent Severe Aplastic Anemia,
Location: Duarte CA
Sponsor: City of Hope Medical Center

Sex: All

Age: 0 - 70+

Code: NCT05757310

Phase 1, Recruiting

Taste Bud-Derived Stem Cells in Humans

for
Diabetes
Location: Baltimore MD
Sponsor: National Institute on Aging (NIA)

Sex: All

Age: 18 - 70+

Code: NCT03366168

Recruiting

Repeat Peripheral Blood Stem Cell Transplantation for Patients With Sickle Cell Disease and Falling Donor Myeloid Chimerism Levels

for
Myeloid Chimerism
Location: Bethesda MD
Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Sex: All

Age: 2 - 70+

Code: NCT04008368

Phase 1, Phase 2, Recruiting

Immunogenicity of Zoster Vaccine in Allogeneic Hematopoietic Stem Cell Transplant Recipients

for
Shingles
Location: Maywood IL
Sponsor: Loyola University

Sex: All

Age: 0+

Code: NCT05554068

Phase 2, Recruiting

Haploidentical Hematopoietic Stem Cell Transplantation With Ex Vivo TCR Alpha/Beta and CD19 Depletion in Pediatric Hematologic Malignancies

for
Pediatric Hematologic Malignancies
Location: St Louis MO
Sponsor: Washington University School of Medicine

Sex: All

Age: 0 - 30

Code: NCT05011422

Phase 1, Recruiting

Darzalex Faspro (Daratumumab and Hyaluronidase-fihj) Before Standard Desensitization and Allogeneic Bone Marrow or Peripheral Blood Stem Cell Transplantation in Adult Patients at High-risk for Primary Graft Failure Secondary to Donor Specific Antibodies

for
Hematologic Malignancy, Bone Marrow Transplant Rejection,
Location: Baltimore MD
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Sex: All

Age: 18+

Code: NCT06398457

Early Phase 1, Recruiting

The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen

for
Acute Myelogenous Leukemia, Acute Lymphocytic Leukemia,
Location: Winston-Salem NC
Sponsor: Wake Forest University Health Sciences

Sex: All

Age: 18 - 70+

Code: NCT01890486

Recruiting

Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

for
Graft vs Host Disease
Location: Bethesda MD, Miami FL
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT05531786

Phase 1, Phase 2, Recruiting

Post-authorization Safety Study of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Treated With Mogamulizumab

for
Leukemia/Lymphoma, Cutaneous T Cell Lymphoma, ATLL
Location: Milwaukee WI
Sponsor: Kyowa Kirin, Inc.

Sex: All

Age: 18+

Code: NCT04014374

Recruiting

What stem cell therapy clinical trials are studying now

Transplants for blood cancers and blood disorders. Hematopoietic stem cell transplant replaces a person's blood forming system with their own stored cells or a donor's. Trials test safer conditioning, better donor matching, including half matched family donors for sickle cell disease, and ways to prevent graft versus host disease.

Transplants for autoimmune disease. Resetting the immune system with a person's own stem cells is being tested against the best available drugs in relapsing multiple sclerosis, in a Phase 3 trial funded by the National Institutes of Health at more than 20 US sites.

Mesenchymal stromal cells. Cells from bone marrow or fat that calm inflammation, tested for Crohn's disease, graft versus host disease, and hard to heal wounds. The first one was approved in 2024 after decades of trials.

Cells made from stem cells. Lab grown dopamine neurons for Parkinson's disease and insulin producing islet cells for type 1 diabetes, both now in or entering late stage trials.

Gene corrected stem cells. A person's own blood stem cells are edited to fix a mutation and returned. Two such therapies for sickle cell disease were approved in 2023; see gene therapy clinical trials. Immune cell therapies such as CAR T are a different technology, covered on our CAR T cell therapy page.

Stem cell transplants are part of care for leukemia, lymphoma, and multiple myeloma; each page lists its own studies.

Article preview image

New to research? Read how informed consent works.

Informed Consent in Clinical Trials: What Is It and How It’s Obtained

Who can participate in stem cell therapy clinical trials?

Is stem cell therapy safe?

How long does stem cell therapy last?

Do stem cell trial participants get paid?

How to enroll in a stem cell clinical trial